AstraZeneca Annual Report and Financial Statements Form 20-F Information 2003 85 19 Provisions for liabilities and charges Environmental, litigation Employee and other Deferred benefits Pensions provisions taxation Total $m $m $m $m $m At 1 January 2002 172 357 163 908 1,600 Profit and loss account 89 43 305 437 Net amounts paid or becoming current 44 235 42 321 Other movements, including exchange 11 23 26 3 57 At 31 December 2002 139 234 190 1,210 1,773 Profit and loss account 50 72 48 232 402 Net amounts paid or becoming current 57 57 65 179 Other movements, including exchange 58 34 30 148 270 At 31 December 2003 190 283 203 1,590 2,266 Employee benefit provisions comprise post-retirement and other employee benefit provisions.
Further details of environmental provisions are given in Note 31.
No provision has been released or applied for any purpose other than that for which it was established.
20 Reconciliation of movements in shareholders funds 2003 2002 2001 $m $m $m Shareholders funds at beginning of year 11,172 9,586 9,389 Net profit for the financial year 3,036 2,836 2,906 Dividends 1,350 1,206 1,225 Profit retained for the financial year 1,686 1,630 1,681 Issues of AstraZeneca PLC Ordinary Shares 47 36 86 Re-purchase of AstraZeneca PLC Ordinary Shares 1,154 1,190 1,080 Foreign exchange adjustments on consolidation, net of tax 1,427 1,106 502 Translation differences on foreign currency borrowings 6 18 Tax on translation differences on foreign currency borrowings 2 6 Net addition to shareholders funds 2,006 1,586 197 Shareholders funds at end of year 13,178 11,172 9,586
